Home04K • FRA
add
Knight Therapeutics Inc
Previous close
€3.64
Day range
€3.72 - €3.72
Year range
€3.40 - €4.10
Market cap
577.84M CAD
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 88.08M | 1.70% |
Operating expense | 40.40M | 3.49% |
Net income | 2.18M | 148.06% |
Net profit margin | 2.48 | 147.24% |
Earnings per share | 0.02 | 150.00% |
EBITDA | 6.05M | -60.32% |
Effective tax rate | 647.62% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 180.86M | -5.84% |
Total assets | 1.00B | 3.60% |
Total liabilities | 207.60M | 0.62% |
Total equity | 795.44M | — |
Shares outstanding | 99.64M | — |
Price to book | 0.46 | — |
Return on assets | -1.41% | — |
Return on capital | -1.63% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 2.18M | 148.06% |
Cash from operations | 3.67M | -88.12% |
Cash from investing | 32.13M | 231.85% |
Cash from financing | -4.70M | -62.20% |
Net change in cash | 32.05M | 686.67% |
Free cash flow | -8.57M | -988.21% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
745
